Secondly, we did not address the potential molecular mechanism underlying the alteration of the low expression of MHC in CDK12-mut PCa, as shown in our patient 17, including epigenetic alterations, miRNA activity, and potential influence of adjuvant therapies on MHC expression and immune TME dynamics. Here, CDK12 is linked to posterior cortical atrophy.